ReviewFrontiers in immunology2023

Reactive oxidative species (ROS)-based nanomedicine for BBB crossing and glioma treatment: current status and future directions.

Dandan Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.